Related Experiment Video
Updated: Aug 12, 2025
11:36
Author Spotlight: An Integrated Workflow to Study the Promoter-Centric Spatio-Temporal Genome Architecture in Scarce Cell Populations
Published on: April 21, 2023
2.3K
SCN1A: bioinformatically informed revised boundaries for promoter and enhancer regions
Susanna Pagni1,2, Helena Martins Custodio1,2, Adam Frankish3
1Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.
Human Molecular Genetics
|January 30, 2023
Summary
Genetic variations in the SCN1A gene cause epilepsy. This study maps the regulatory regions of SCN1A, identifying promoters and enhancers to understand epilepsy causes better.
Area of Science:
- Genetics
- Neuroscience
- Molecular Biology
Background:
- Pathogenic variations in the SCN1A gene are linked to various epilepsy types, including Dravet syndrome and febrile seizures.
- The phenotypic diversity in SCN1A-related epilepsies suggests regulatory factors may play a role, but the SCN1A regulatory landscape is not fully understood.
Purpose of the Study:
- To comprehensively summarize the regulatory landscape of the SCN1A gene.
- To identify and define SCN1A promoter and enhancer regions.
- To explore the role of SCN1A regulatory regions in epilepsy.
Main Methods:
- Integrated data from genome-wide repositories to define SCN1A promoter and enhancer regions.
- Analyzed cellular specificity of SCN1A promoter usage.
- Reviewed human and mouse brain-derived enhancer databases for SCN1A activity.
Main Results:
- Defined promoter and enhancer regions of the SCN1A gene.
- Identified cell-specific promoter usage.
- Created a comprehensive catalogue of SCN1A brain-active enhancers by integrating diverse evidence.
Conclusions:
- A detailed map of SCN1A regulatory regions has been established.
- This catalogue provides a resource for investigating the contribution of SCN1A regulatory variations to epilepsy.
- Further research can utilize this data to explore genotype-phenotype correlations in SCN1A-related epilepsies.
